跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 于翔
主治醫師
,
臺北市立萬芳醫院
電子郵件
62258
w.tmu.edu
tw
h-index
5
引文
1
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2017
2024
每年研究成果
概覽
指紋
網路
研究成果
(4)
類似的個人檔案
(6)
指紋
查看啟用 Yu-Hsiang Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Sapindus mukorossi
100%
Melanogenesis
50%
Tyrosinase
50%
Melanocyte-Stimulating Hormone
50%
Animal Experiment
50%
Androgen Receptor
50%
Independent Pathway
50%
Mucosa
50%
Complement Factor B
50%
Unsaturated Fatty Acid
25%
Pigmentation
20%
Cancer Cell
18%
Stem Cell
16%
Signal Transduction
12%
Cell Growth
11%
Micro-Computed Tomography
11%
Bone Growth
11%
Cell Viability
10%
Photobleaching
10%
Lipid Composition
10%
Free Fatty Acids
10%
Gas Chromatography-Mass Spectrometry
10%
High-Performance Liquid Chromatography
10%
MTT Assay
10%
Cytotoxicity
10%
Paracaspase
6%
Carcinogenesis
6%
Gene Linkage
6%
Cell Invasion
6%
LNCaP
6%
N-Myc
6%
Prostate-Specific Antigen
6%
Tumor Progression
6%
Quantitative Technique
5%
Gene Expression
5%
Bone Development
5%
Animal Model
5%
New Zealand White (Rabbit)
5%
Real-Time Polymerase Chain Reaction
5%
Secretion (Process)
5%
In Vivo Study
5%
Bone Regeneration
5%
Ossification
5%
Pharmacology, Toxicology and Pharmaceutical Science
Sapindus mukorossi
100%
Vegetable Oil
100%
Fatty Acid
50%
Tyrosinase
50%
Intermedin
50%
Unsaturated Fatty Acid
37%
Sitosterol
33%
Hyperpigmentation
33%
Melanin
33%
Cytotoxicity
16%
Hyperbarism
16%
Melanoma
16%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
16%
Pigment Disorder
16%
Cell Viability
16%
Adverse Event
16%
Bone Defect
9%
Medicine and Dentistry
Carcinoma Cell
50%
Mucosa-Associated Lymphoid Tissue
50%
Nuclear Factor
50%
Androgen Receptor
50%
Prostate Carcinoma
50%
Alternative Complement Pathway C3 C5 Convertase
50%
Androgen
50%
Prostate Cancer
25%
Cancer Cell
18%
Signal Transduction
12%
Neoplasm
6%
Paracaspase
6%
Cell Growth
6%
Gene Linkage
6%
Cell Invasion
6%
Prostate Specific Antigen
6%
In Vitro
6%
Malignant Neoplasm
6%
Tumor Progression
6%
Carcinogenesis
6%
